📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion (2016)

First Author: Bullock N

Attributed to: Anti-angiogenic compounds based on modulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jclinpath-2015-203125

PubMed Identifier: 26500332

Publication URI: http://europepmc.org/abstract/MED/26500332

Type: Journal Article/Review

Parent Publication: Journal of Clinical Pathology

Issue: 2

ISSN: 0021-9746